跳至主要内容
临床试验/NCT01760941
NCT01760941终止不适用

Feasibility of a Compassionate Same-Day Evaluation and Delivery of Single Fraction Radiotherapy for Palliation of Symptomatic Bony Metastasis in Hospice Patients

Virginia Commonwealth University2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2013年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
2
主要终点
Feasibility of Treatment Delivery in the Same Day as Initial Evaluation

研究概览

简要总结

This is a survey study to evaluate the feasibility and effectiveness of an affordable, $400 flat rate, same-day consultation, simulation, and delivery of a single fraction of palliative radiation therapy for patients with symptomatic bony metastatic disease who are currently enrolled in hospice. Treatment planning and delivery of palliative radiotherapy will utilize "standard of care" techniques.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic osseous bone lesion(s) from any malignancy, whether primary of metastatic, with histological confirmation of malignancy.
  • Currently enrolled in hospice and referred for single fraction palliative radiotherapy.
  • Performance status (to be evaluated by the radiation oncologist), Karnofsky Performance Scale ≥ 20 or ECOG Performance Scale < 5 .
  • Ability to understand and willingness to sign a written informed consent document

排除标准

  • Pregnancy.
  • Unable to understand English.
  • Unable to complete forms with assistance.
  • Concurrent enrollment in a study of pain management involving medications or devices.

结局指标

主要结局

Feasibility of Treatment Delivery in the Same Day as Initial Evaluation

时间窗: Up to 6 months

Patient evaluation will consist of surveys conducted at the time of treatment measured by the Radiation Oncologist Evaluation and Feasibility Assessments survey

次要结局

  • Evaluate the Treatment Influence on Patient Quality of Life(2 weeks)
  • Evaluate the Treatment Influence on the Rate of Pain Stabilization and/or Reduction(2 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验